학술논문
A Phase II Trial of a Personalized, Dose-Intense Administration Schedule of 177Lutetium-DOTATATE in Children With Primary Refractory or Relapsed High-Risk Neuroblastoma-LuDO-N
Document Type
Artikel
Author
Source
Frontiers in pediatrics. 10:836230
Subject
Language
English
English
English
ISSN
2296-2360